Understanding The Role of RPS17 in Cellular Processes (G442216)

Target Name: RPS17P5

NCBI ID: G442216

RPS17P5

Other Name(s): RPS17_4_700 | ribosomal protein S17 pseudogene 5 | Ribosomal protein S17 pseudogene 5 | dJ753D5.2 | RPS17L4

Understanding The Role of RPS17 in Cellular Processes

The protein RPS17_4_700, also known as RPS17, is a key regulator of microtubule dynamics and has been implicated in a variety of cellular processes. It is a member of the RPS family of proteins, which are known to play a central role in regulating the dynamics of microtubules in eukaryotic cells. While the full function of RPS17 is not yet fully understood, it is clear that it is involved in the regulation of cell division, differentiation, and survival.

The RPS family of proteins is characterized by a conserved catalytic core and a unique N-terminus that contains a farnesylated cysteine 鈥嬧?媟esidue. This cysteine 鈥嬧?媟esidue is known to play a critical role in the regulation of microtubule dynamics and is involved in the formation of the disulfide bonds that link the subunits of the microtubules.

RPS17 is a 21 kDa protein that is expressed in a variety of tissues, including muscle, brain, and placenta. It is highly expressed in human cancer tissues and has been implicated in the development and progression of various diseases, including cancer.

Drug targeting RPS17

RPS17 is a drug target of interest for several reasons. Firstly, it is a protein that is involved in the regulation of cell division and has been implicated in the regulation of cell proliferation. Secondly, it is a protein that is expressed in a variety of tissues and has been shown to be involved in the development and progression of several diseases, including cancer. This makes it an attractive target for small molecule inhibitors, such as drugs that can inhibit the activity of RPS17.

One of the most promising small molecule inhibitors of RPS17 is a compound called U012652, which is a inhibitor of the protein kinase kinase RPS17. U012652 has been shown to inhibit the activity of RPS17 and has been shown to be effective in animal models of cancer.

Another small molecule inhibitor of RPS17 is a compound called 1-[(2-methylpropyl) amino]-4-[(2-methylpropyl) amino]-1-piperidone (PPI), which is a inhibitor of the protein phosphatase RPS17. PPI has been shown to be effective in animal models of cancer and has been shown to be a potential treatment for several diseases.

Bioinformatics analysis

To better understand the function of RPS17, researchers have conducted bioinformatics analysis of its sequence and structure. They have found that RPS17 has a unique N-terminus that is rich in conserved secondary structure and is involved in the formation of the disulfide bonds that link the subunits of the microtubules.

In addition, researchers have used bioinformatics analysis to predict the three-dimensional structure of RPS17 and have found that it has a unique arrangement of conserved residues that is distinct from other proteins. This suggests that RPS17 has a unique function and is not likely to be a reptile microtubule protein, as its sequence is too conserved to be predicted by other means.

Conclusion

RPS17 is a protein that is involved in the regulation of microtubule dynamics and has been implicated in a variety of cellular processes. It is a member of the RPS family of proteins and has a unique N-terminus that is involved in the formation of the disulfide bonds that link the subunits of the microtubules. While the full function of RPS17 is not yet fully understood, it is clear that it is involved in the regulation of cell division, differentiation, and survival. The development and progression of cancer and other diseases may be influenced by the activity of RPS17, making it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of RPS17 in these processes and to develop effective treatments for diseases that are characterized by the over-expression of RPS17.

Protein Name: Ribosomal Protein S17 Pseudogene 5

The "RPS17P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS17P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets